A group of experts gathered to discuss microdosing and separate the fact from the fiction regarding the safety and efficacy...
Heroic Hearts UK CEO Keith Abraham discusses his journey to setting up the organisation which aims to help veterans living with PTSD.
Mindset Pharma says its next-generation psilocybin compounds could change the paradigm of microdosing by limiting the psychedelic effect.
People will now be able to participate in psychedelic-assisted therapy in a group setting as the Institute for Integrative Therapies expands its services to support the...
Awakn Life Sciences will be carrying out the first-ever study investigating the use of ketamine treatment for gambling addiction, using psychedelic-assisted psychotherapy.
Diamond Therapeutics has received approval from Health Canada to carry out a clinical trial for the treatment of mental health conditions with low-dose psilocybin.
A new review has suggested mixing classic psychedelics with lithium could pose a heightened risk of seizures.
Psychedelics company Silo Wellness has today announced a UK distribution partnership for its Marley One functional mushroom products.
Freya Masters is a recent graduate from the University of St Andrews where she studied biochemistry.
A national poll has revealed a clear majority of people in the UK are in favour of research into the medical potential of psilocybin.
